Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

about

Docking Screens for Novel Ligands Conferring New Biology.

P2860

Q30489011-F9A42B6B-EF31-4310-BAE6-97F488F5C159

P2860

Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

Item

http://www.wikidata.org/entity/Q38888719

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Combination of pharmacophore h ...... bitors of HCV NS5B polymerase.

@en

type

Item

label

Combination of pharmacophore h ...... bitors of HCV NS5B polymerase.

@en

prefLabel

Combination of pharmacophore h ...... bitors of HCV NS5B polymerase.

@en

P1476

Combination of pharmacophore h ...... bitors of HCV NS5B polymerase.

@en

P2093

Amaravadhi Harikishore

http://www.w3.org/2001/XMLSchema#string

Enlin Li

http://www.w3.org/2001/XMLSchema#string

Jia Jun Lee

http://www.w3.org/2001/XMLSchema#string

Nam-Joon Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5A

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus

Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.

Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study

Fragment-based discovery of hepatitis C virus NS5b RNA polymerase inhibitors

Discovery of (R)-6-cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a potent and orally available hepatitis C virus polymerase inhibitor

Identification and biological evaluation of a series of 1H-benzo[de]isoquinoline-1,3(2H)-diones as hepatitis C virus NS5B polymerase inhibitors

Cyclic amide bioisosterism: strategic application to the design and synthesis of HCV NS5B polymerase inhibitors

Quinolones as HCV NS5B polymerase inhibitors

P2888

s11030-015-9591-5

P304

529-539

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11030-015-9591-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ho Sup Yoon

P577

2015-04-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274781533

http://www.w3.org/2001/XMLSchema#string

P698

25862642

http://www.w3.org/2001/XMLSchema#string

Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

about

P2860

P2860

Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P698